Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Qualigen Therapeutics Inc. buy Maxfloh

Qualigen Therapeutics Inc.
Start price
€710.33
07.01.18 / 50%
Target price
€1,353.0
05.11.18
Performance (%)
-61.27%
End price
€275.10
05.11.18
Summary
This prediction ended on 05.11.18 with a price of €275.10. The BUY prediction by Maxfloh for Qualigen Therapeutics Inc. performed very badly with a performance of -61.27%. Maxfloh has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Qualigen Therapeutics Inc. -10.000% -10.000% -81.143% -98.680%
iShares Core DAX® -5.744% -6.037% 9.155% 8.257%
iShares Nasdaq 100 -4.907% -12.083% 19.607% 30.219%
iShares Nikkei 225® -7.230% -10.182% 3.445% -1.121%
iShares S&P 500 -4.764% -6.545% 19.194% 31.957%

Comments by Maxfloh for this prediction

In the thread Ritter Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -61.27%
Target price 5.412
Change
Ends at 05.11.18

Pleitekandidat oder Vervielfacher?

  1. ​günstige Marktkapitalisierung
  2. Kapitalerhöhung ist erfolgreich verlaufen
  3. beginn der Phase 3 Studie von RP-G28 ab Frühjahr 2018

Ritter Pharmaceuticals ist ein führender Pharmaforscher im Bereich der Laktoseintoleranz

Maxfloh 
0
Report Share
07.01.18
Prediction Buy
Perf. (%) -61.27%
Target price 5.412
Change
Ends at 05.11.18

(Vom Mitglied beendet)

Maxfloh 
0
Report Share
05.11.18

Stopped prediction by Maxfloh for Qualigen Therapeutics Inc.

buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.20
19.08.19
€400.00
13.09.19
-
13.09.19

Maxfloh 
19.08.19 50%